FTC Chair Khan Issues Remarks on Rebates, Fees in Exchange for Excluding Lower-Cost Drug Products
June 17, 2022
June 17, 2022
WASHINGTON, June 17 -- The Federal Trade Commission issued the following remarks on June 16, 2022, by Chairwoman Lina Khan on the policy statement on rebates and fees in exchange for excluding lower-cost drug products (Commission File No. P221201):
* * *
The Federal Trade Commission is voting on a policy statement that lays out concerns about certain business practices that may be resulting in Americans having to pay higher prices for essential medicines.
F . . .
* * *
The Federal Trade Commission is voting on a policy statement that lays out concerns about certain business practices that may be resulting in Americans having to pay higher prices for essential medicines.
F . . .